Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
Laboratoire d'étude des greffes et prothèses cardiaques, Hôpital Broussais, Paris, France.
C
C
Latremouille
N
N
Haeffner-Cavaillon
N
N
Goussef
C
C
Mandet
N
N
Hinglais
P
P
Bruneval
J
J
Bariety
A
A
Carpentier
D
D
Glotz
D000208:Acute Disease; D000818:Animals; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D051381:Rats; D011917:Rats, Inbred Lew; D013997:Time Factors; D014183:Transplantation, Heterologous; D016042:Transplantation, Heterotopic
D016756:Immunoglobulins, Intravenous